What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis).

October 5, 2025

Data from Racial and Ethnic Disparities in Survival among Patients with Cholangiocarcinoma in the United States: A Systematic Review and Meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

Systematic review reveals racial disparities in cholangiocarcinoma survival and treatment among patients, suggesting the need for targeted research.

Black patients with cholangiocarcinoma have worse survival rates compared to Hispanic and Asian patients.
Overall survival analysis showed a pooled hazard ratio of 1.05 for Black patients indicating poorer outcomes.
Systematic review combined 16 studies, reporting on 248,109 patients to assess racial and ethnic disparities.
Improving health equity is crucial, as disparities in CCA outcomes highlight the need for further action.

Shubin et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Systematic review reveals racial disparities in cholangiocarcinoma survival and treatment among patients, suggesting the need for targeted research.